Delisting risk
Decoy Therapeutics (DCOY)
Developer of peptide-conjugate antivirals against shared viral fusion machinery.
$2.82
Pre-market−0.17 (−5.69%)
At close$2.99(−2.29%)
Something off on this page? Send us feedback.
Next report
Nov 13, 2026
in 71 days
EPS estimate
−$3.12
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Nov '25Apr '26May '26May '26Aug '26Nov '26
Reported−$15.44−$6.75−$1.81−$99.99−$4.18−$4.18−$4.46Pending
Estimate−$36.00−$33.00−$33.60−$6.48−$4.12−$4.12−$2.88−$3.12
Surprise+57.1%+79.5%+94.6%−1,443.1%−1.4%−1.4%−54.9%—
RevenueReportedEstimate
May '25Aug '25Nov '25Apr '26May '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$3.12 | — | — |
| Aug 2026 | −$2.88 | −$4.46 | −54.9% |
| May 2026 | −$4.12 | −$4.18 | −1.4% |
| May 2026 | −$4.12 | −$4.18 | −1.4% |
| Apr 2026 | −$6.48 | −$99.99 | −1,443.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$3.12 | — | — | — | — | — | — |
| Aug 12, 2026 | −$2.88 | −$4.46 | −54.9% | — | — | — | −7.0% |
| May 13, 2026 | −$4.12 | −$4.18 | −1.4% | — | — | — | −6.2% |
| May 8, 2026 | −$4.12 | −$4.18 | −1.4% | — | — | — | −4.9% |
| Apr 3, 2026 | −$6.48 | −$99.99 | −1,443.1% | — | — | — | +1.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Nov 14, 2025 | |||||||
| Aug 12, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 21, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 22, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 27, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 10, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 12, 2021 | |||||||
| Mar 18, 2021 | |||||||
| Nov 11, 2020 | |||||||
| Aug 12, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 23, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Jul 17, 2019 | |||||||
| May 1, 2019 | |||||||
| Mar 6, 2019 | |||||||
| Nov 5, 2018 | |||||||
| Aug 1, 2018 | |||||||
| May 2, 2018 | |||||||
| Mar 7, 2018 | |||||||
| Nov 6, 2017 | |||||||
| Aug 2, 2017 | |||||||
| May 3, 2017 | |||||||
| Mar 8, 2017 | |||||||
| Nov 2, 2016 | |||||||
| Aug 3, 2016 | |||||||
| May 4, 2016 | |||||||
| Mar 8, 2016 | |||||||
| Nov 4, 2015 | |||||||